BioSpace News Archive

In a recent market research report, TMR Research presents an assessment of the growth dynamics and the key factors affecting the overall pace of development of the global market for next generation sequencing. The report is titled “Next-Generation Sequencing (NGS) Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017–2025.”

The optical microscope market is witnessing a healthy growth thanks to the development of newer production technologies, which have simplified the manufacturing and assembling processes.

Pharmerging market, as the name suggests pertains to the emerging pharmaceutical markets. The global pharmerging market is anticipated to display an attractive growth in the foreseeable future owing to the low cost of generic drugs.

Innophos Holdings, Inc., a leading international producer of essential ingredients, today announced the launch of Oxyjun® Terminalia arjuna aqueous extract, expanding its portfolio of targeted sports performance and active nutrition ingredients

Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), today announced that it will report its fourth quarter and year ended December 31, 2019 financial results after the close of market on Thursday, February 27, 2020.

Applied Biomics, Inc., a leading Proteomics service provider, adds a HCP profiling analysis using their well established high resolution, large format 2-Dimensional Differential In-Gel Electrophoresis (2D DIGE) platform

RIBOMIC, Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics and traded on the Mothers Market of the Tokyo Stock Exchange (Code Number: 4591), today announced that first patient has received injection in the phase 2 trial of RBM-007 for the treatment of exudative age-related macular degeneration (AMD) in the United States.

Worldwide Clinical Trials, Inc. announced that Mike Mencer has joined the company as the EVP and General Manager of Worldwide’s Early Phase Services, focusing on the Bioanalysis Lab in Austin, Texas, and the Clinical Pharmacology Unit clinic in San Antonio, Texas.

Asklepios BioPharmaceutical, Inc., a leading clinical-stage adeno-associated virus gene therapy company, announced that it has appointed scientific leader Anna Tretiakova, PhD, as Senior Vice President of Product Development.

In the past few years research and development of CRISPR or clustered regularly interspaced short palindromic repeats has allowed molecular biologists to designs solutions for repairing cells by genome editing.